"- Revenues, exclusive of our test systems business unit, were $8.9 million for the fourth quarter of 2008 and $36.9 million for the full year, an increase of 9% and 43%, respectively.
- Gross margin was 29% for the fourth quarter of 2008 and 20% for the full year, increases of 16 and 8 percentage points, respectively.
- EBITDA loss was $2.0 million for the fourth quarter of 2008 and $14.4 million for the full year, a reduction of $7.6 million or 79% and $16.9 million or 54%, respectively.
- Cash and cash equivalents, restricted cash and short-term investments were $22.7 million at December 31, 2008, a nominal $0.5 million sequential reduction from the third quarter of 2008.
- Ending backlog was $22.2 million, more than 90% of which is anticipated to be delivered and recognized as revenue in 2009."
http://hydrogenics.com/ir_newsdetail.asp?RELEASEID=372806 http://ca.news.yahoo.com/s/capress/090325/business/hydrogenics |